PROBIOTIKA LV has developed innovative bio cellulose dressing for wound treatment (BC SKIN) to be part of the global shift from conventional wound dressings to biomaterial dressings that are significantly better. BC SKIN has antibacterial properties that reduce the wound treatment time. BC SKIN product should be changed less frequently as alternatives. Healthcare service providers benefits greatly by reduced treatment time and costs. This lead us to define our Unique Selling Point which is – best antibacterial wound dressing for short healing time and low changing frequency. This will allow for massive shift in medical industry enabling end users to better heal their wounds with less costs associated.
Product tests showed that BC SKIN product is the best designed in three sizes for different wounds: 3 x 5 cm, 2 x 6 cm, 5 x 10 cm. Thickness is 0,5 mm. Bacterial cellulose dressings can be used: I-II degree burns, cut wound, diabetic, venous, arterial ulcers, bedsores, on wounds after laser grinding. The project allowed us to develop application guidelines, product certification and packaging requirements. We have identified the best antibacterial additive that is furagin that allows wound to heal more faster.
Interviews with relevant users helped to understand that material should have ventilating properties (so that the skin can breathe). It must not allow any “outside” microorganisms to encounter the wound. The material must have absorbing and treatment properties. Healthcare service providers are interested in new cost effective methods or treating wounds.
Our market research and financial projections show that further development of the product and manufacturing equipment is feasible and will generate substantial profits. We understand our risks and they are quite substantial however the product for itself is needed by the industry therefore we will continue to develop it. It is obvious that for our business industrial partner is required and additional EU or private funding.
